These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16507390)

  • 21. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells.
    Dhawan D; Jeffreys AB; Zheng R; Stewart JC; Knapp DW
    Mol Cancer Ther; 2008 Apr; 7(4):897-904. PubMed ID: 18413803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
    Li W; Jiang HR; Xu XL; Wang J; Zhang J; Liu ML; Zhai LY
    Int J Mol Sci; 2010 Oct; 11(10):3999-4013. PubMed ID: 21152316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of nonsteroidal anti-inflammatory drug celecoxib on expression of cyclooxygenase-2 (COX-2) in ovarian carcinoma cell].
    Wang HJ; Liu XJ; Yang KX; Luo FM; Lou JY; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):757-60. PubMed ID: 17037745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of celecoxib on the proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2].
    Xu X; Yi F; Fu X; Li D; Huang Q; Du J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 23(15):682-5. PubMed ID: 19947251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
    Gee JR; Burmeister CB; Havighurst TC; Kim K
    Anticancer Res; 2009 Oct; 29(10):3769-75. PubMed ID: 19846907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration.
    Kuipers GK; Slotman BJ; Wedekind LE; Stoter TR; Berg Jv; Sminia P; Lafleur MV
    Int J Radiat Biol; 2007 Oct; 83(10):677-85. PubMed ID: 17729162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
    Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of celecoxib on PGE2 synthesis and COX-2 and VEGF-C mRNA expression in Tca8113 cell lines].
    Li WZ; Wang XY; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):466-8. PubMed ID: 19304526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines.
    Lev-Ari S; Kazanov D; Liberman E; Ben-Yosef R; Arber N
    Dig Dis Sci; 2007 Apr; 52(4):1128-33. PubMed ID: 17342386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J
    Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function.
    Yan YX; Li WZ; Huang YQ; Liao WX
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):29-35. PubMed ID: 21835258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells].
    Wang CH; Ouyang Q; Tang CW; Huang MH; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):547-50. PubMed ID: 16909598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A₂ and peroxisome proliferator-activated receptor gamma.
    Zhang M; Xu ZG; Shi Z; Shao D; Li O; Li W; Li ZJ; Wang KZ; Chen L
    Mol Cell Biochem; 2011 Sep; 355(1-2):233-40. PubMed ID: 21559762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
    Tuynman JB; Buskens CJ; Kemper K; ten Kate FJ; Offerhaus GJ; Richel DJ; van Lanschot JJ
    Ann Surg; 2005 Dec; 242(6):840-9, discussion 849-50. PubMed ID: 16327494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.